Jane Street’s Coya Therapeutics COYA Stock Holding History

Jane Street’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$345K	Sell	58,900 -4,500	-7%	-$20.8K	﹤0.01%	8903
2026 Q1	$250K	Buy	+63,400	New	+$296K	﹤0.01%	9631

Other funds holding COYA

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Jane Street's COYA Position: Q2 2026 in Review

Jane Street sold out of Coya Therapeutics (COYA) in Q2 2026, closing a stake of 13,340 shares — an estimated $61.8K sold.

Jane Street first reported a position in COYA in Q1 2024 and held it in 6 quarters. The position peaked at $199K in Q1 2024. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

Jane Street reported no remaining Coya Therapeutics position as of Q2 2026 after selling out during the quarter.
Jane Street sold 13,340 Coya Therapeutics shares in Q2 2026, an estimated $61.8K.
Jane Street first reported a position in Coya Therapeutics in Q1 2024 and held it in 6 quarters.
Jane Street's Coya Therapeutics position peaked at $199K in Q1 2024.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.